Overall, mutated genes identified in the tumor‐enriched cohort were concordant, with recurrent variants identified in TET2, DNMT3A, RHOA, IDH2, and TET3 (Figures 1A and S4E). The gene discussed is IDH2; the disease is neoplasm.